Evidence map›Paper›PMID 40966716›Full record

ArticleBrain : a journal of neurology2026

Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophy.

Florian Gerstner, Sandra Wittig, Christian Menedo, Sayan Ruwald, Maria J Carlini, Adela Vankova, Leonie Sowoidnich, Gerardo Martín-López, Vanessa Dreilich, Andrea Alonso-Collado and 10 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Cerebellar pathology in spinal muscular atrophy.Nature reviews. Neurology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Florian GerstnerCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Sandra WittigCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Christian MenedoCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Sayan RuwaldCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Maria J CarliniDepartment of Neurology, Columbia University, New York, NY 10032, USA.
Adela VankovaCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Leonie SowoidnichCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Gerardo Martín-LópezCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Vanessa DreilichCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Andrea Alonso-ColladoCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
John G PagiazitisDepartment of Neurology, Columbia University, New York, NY 10032, USA.
Oumayma AousjiDepartment of Neurology, Center for Biomedical Research (ZBF), Ulm University, Ulm, Baden-Württemberg 89081, Germany.
Chloe GrzybCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.
Amy K SmithDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Mu YangMouse Neurobehavioral Core Facility, Columbia University, New York, NY 10032, USA.
Francesco RoselliDepartment of Neurology, Center for Biomedical Research (ZBF), Ulm University, Ulm, Baden-Württemberg 89081, Germany.ORCID 0000-0001-9935-6899
George Z MentisDepartment of Neurology, Columbia University, New York, NY 10032, USA.
Charlotte J SumnerDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Livio PellizzoniDepartment of Neurology, Columbia University, New York, NY 10032, USA.
Christian M SimonCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Saxony 04103, Germany.

Funding

Mechanisms of Central Synaptic Dysfunction in SMAR01NS078375 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2012 to 2026
$6.6M
Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesR35NS122306 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Charlotte Jane Sumner · 2021 to 2026
$6.3M
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular AtrophyR01NS102451 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Livio Pellizzoni · 2017 to 2026
$3.9M
Essential role of Stasimon in motor circuit development and diseaseR01NS114218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.9M
Cellular and Neuronal Circuit Mechanisms Involved in Locomotor ActivityR01NS125362 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2023 to 2026
$2.5M
Mechanisms and Therapeutic Targeting of Motor Neuron Death in SMAR01NS116400 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.3M
German Research Foundation SI 1969/7-1NIH HHS R01NS078375NIH HHS R01NS102451NIH HHS R01NS114218NIH HHS R01NS116400NIH HHS R01NS125362NINDS NIH HHS R01 NS078375NINDS NIH HHS R01 NS102451NINDS NIH HHS R01 NS114218NINDS NIH HHS R01 NS116400NINDS NIH HHS R01 NS125362NINDS NIH HHS R35 NS122306
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is a neuromuscular disease characterized by ubiquitous survival motor neuron (SMN) deficiency and loss of motor neurons. The persistence of motor and communication impairments, together with emerging cognitive and social deficits in severe type I SMA patients treated early with SMN-restoring therapies, suggests a broader dysfunction involving neural circuits of the brain. To explore the potential supraspinal contributions to these emerging phenotypes, we investigated the cerebellum, a brain region crucial for both motor and cognitive behaviours. Here, we identify cerebellar pathology in both post-mortem tissue from type I SMA patients and a severe mouse model, which is characterized by lobule-specific Purkinje cell death driven by cell-autonomous, non-apoptotic p53-dependent mechanisms. Loss and dysfunction of excitatory parallel fibre synapses onto Purkinje cells contribute further to cerebellar circuit disruption and altered Purkinje cell firing. Furthermore, we identified impaired ultrasonic vocalization (a proxy for early-developing social communication skills that depend on cerebellar function) in a severe SMA mouse model. Cell-specific rescue experiments demonstrate that intrinsic cerebellar pathology contributes to motor and social communication impairments independently of spinal motor circuit abnormalities. Together, these findings establish cerebellar dysfunction as a pathogenic driver of neurodevelopmental motor and social defects, providing mechanistic insight into the persisting and emerging phenotypes of SMA.

Indexed as

CerebellumMuscular Atrophy, SpinalNeurodevelopmental DisordersAnimalsDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred C57BLMotor NeuronsPurkinje Cellsautism-like behaviourcerebellar circuit dysfunctionmotor neuron diseasesneuronal deathsocial deficits

Identifiers

PMID40966716
PMCPMC12908613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.